Skip to main content
Have a personal or library account? Click to login
Antineoplastic Drugs: Occupational Exposure and Side Effects Cover

References

  1. Anonymous (2012). Antineoplastic drugs: Hazardous, handle with care. ONA (Ontario Nurses Association) – Local 100 Newsletter, December, 7–13.
  2. Buschini, A., Villarini, M., Feretti, D., Mussi, F., Dominici, L., Zerbini, I., Moretti, M., Ceretti, E., Bonfiglioli, R., Carrieri, M., Gelatti, U., Rossi, C., Monarca, S., Poli, P. (2013). Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: Assessment of DNA damage. Occup. Environ. Med.,70 (11), 789–794.10.1136/oemed-2013-10147524143019
  3. Gómez-Olivįn, L. M., Miranda-Mendoza, G. D., Cabrera-Galeana, P. A., Galar-Martínez, M., Islas-Flores, H., SanJuan-Reyes, N., Neri-Cruz, N., García-Medina, S. (2014). Oxidative stress induced in nurses by exposure to preparation and handling of antineoplastic drugs in Mexican hospitals: A multicentric study. Oxid. Med. Cell. Longevity,2014, 7.10.1155/2014/858604395641924719678
  4. Keat, C. H., Sooaid, N. S., Yun, C. Y., Sriraman, M. (2013). Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: Pharmacists’ experience in a general hospital, Malaysia. Asian Pacif. J. Cancer Prevent., 14 (1), 69–73.10.7314/APJCP.2013.14.1.69
  5. Lawson, C. C., Rocheleau, C. M., Whelan, E. A., Lividoti Hibert, E. N., Grajewski, B., Spiegelman, D., Rich-Edwards, J. W. (2012). Occupational exposures and spontaneous abortion. Amer. J. Obstetrics Gynecol., 206 (4), e1–e8.
  6. Momeni, M., Danaei, M., Askarian, M. (2013). How do nurses manage their occupational exposure to cytotoxic drugs? A descriptive survey in chemotherapy settings, Shiraz, Iran. Int. J. Occup. Environ. Med., 4 (2), 102–106.
  7. Anonymous (2014). NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2014. U.S. Department of Health and Human Services Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2014-138.
  8. Shahrasbi, A. A., Afshar, M., Shokraneh, F., Monji, F., Noroozi, M., Ebrahimi-Khojin, M., Madani, S. F., Ahadi-Barzoki, M., Rajabi, M. (2014). Risks to health professionals from hazardous drugs in Iran: A pilot study of understanding of healthcare team to occupational exposure to cytotoxics. Exper. Clin. Sci. Int. Online J. Adv. Sci.,13, 491–501.
  9. Villarini, M., Dominici, L., Fatigoni, C., Muzi, G., Monarca, S., Moretti, M. (2012). Biological effect monitoring in peripheral blood lymphocytes from subjects occupationally exposed to antineoplastic drugs: Assessment of micronuclei frequency. J. Occup. Health, 54 (9), 405–415.10.1539/joh.12-0038-OA22986622
  10. Yu Wen, H., Le, J., Mei, Bian, Z. Quan, Z., Xiao Feng, Y., Xu Dong, H., Ying, Z., Ji Liang, H. (2012). An investigation of oxidative DNA damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay. Biomed. Environ. Sci.,25 (1), 109–116.
DOI: https://doi.org/10.1515/prolas-2016-0049 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 325 - 329
Submitted on: Nov 3, 2015
Published on: Nov 30, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2016 Kristīne Ivanova, Marija Avota, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.